Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jun;11(6):535-44.
doi: 10.1016/S1474-4422(12)70133-3. Epub 2012 May 16.

Aquaporin 4 and neuromyelitis optica

Affiliations
Review

Aquaporin 4 and neuromyelitis optica

Marios C Papadopoulos et al. Lancet Neurol. 2012 Jun.

Abstract

Neuromyelitis optica is an inflammatory demyelinating disorder of the CNS. The discovery of circulating IgG1 antibodies against the astrocyte water channel protein aquaporin 4 (AQP4) and the evidence that AQP4-IgG is involved in the development of neuromyelitis optica revolutionised our understanding of the disease. However, important unanswered questions remain--for example, we do not know the cause of AQP4-IgG-negative disease, how astrocyte damage causes demyelination, the role of T cells, why peripheral AQP4-expressing organs are undamaged, and how circulating AQP4-IgG enters neuromyelitis optica lesions. New drug candidates have emerged, such as aquaporumab (non-pathogenic antibody blocker of AQP4-IgG binding), sivelestat (neutrophil elastase inhibitor), and eculizumab (complement inhibitor). Despite rapid progress, randomised clinical trials to test new drugs will be challenging because of the small number of individuals with the disorder.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The University of California San Francisco and the University of Colorado have filed a joint US provisional patent application for aquaporumab antibody treatment for neuromyelitis optica, of which ASV is a named co-inventor. The intellectual property rights are owned by the University of California and the University of Colorado. MCP declares that he has no conflicts of interest.

Figures

Figure 1
Figure 1. The astrocyte water channel AQP4
(A) High-resolution crystal structure of human AQP4 (Protein Data Bank reference 3GD8) showing eight membrane-associated helical segments, labelled M1–M8. (B) Freeze-fracture electron microscopy of AQP4 orthogonal arrays of particles in plasma membranes of Chinese hamster ovary cells transfected with M23-AQP4. (C) Protein sequence of human AQP4, showing Met-1 and Met-23 translation inhibition sites (black), residues that form intermolecular N-terminus associations to produce orthogonal arrays of particles (pink), residues preventing formation of orthogonal arrays of particles by M1-AQP4 (green), cysteine residues involved in palmitolyation-regulated assembly of orthogonal arrays of particles (blue), and the C-terminus PDZ domain (red).
Figure 2
Figure 2. Formation of neuromyelitis optica lesion
(A) Normal CNS with AQP4-IgG in the serum. (B) At the start of lesion formation, AQP4-IgG binds to AQP4 on foot processes of astrocytes, activates complement, and causes deposition of membrane attack complexes. (C) Cytokines (eg, interleukin 17, interleukin 8, and granulocyte colony-stimulating factor) recruit neutrophils and eosinophils into perivascular spaces; neutrophils degranulate to cause astrocyte death. Loss of astrocytes leads to oligodendrocyte death, which causes axon degeneration (D), and neuronal death (E). Infiltrating macrophages (and possibly microglia) phagocytose cellular and myelin debris. (F) Mature lesions are characterised by pan-necrosis (complete tissue necrosis), and widespread infiltration by macrophages; AQP4-positive reactive astrocytes are confined around the lesion.
Figure 3
Figure 3. Potential targets for treatment
OAP=orthogonal array of particles.

References

    1. Jarius S, Wildemann B. ‘Noteomielite’ accompanied by acute amaurosis (1844): an early case of neuromyelitis optica. J Neurol Sci. 2012;313:182–84. - PubMed
    1. Jarius S, Wildemann B. The case of the Marquis de Causan (1804): an early account of visual loss associated with spinal cord inflammation. J Neurol Sci. 2012;313:182–84. - PubMed
    1. Jarius S, Wildemann B. An early case of neuromyelitis optica: on a forgotten report by Jacob Lockhart Clarke, FRS. Mult Scler. 2011;17:1384–86. - PubMed
    1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–12. - PubMed
    1. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202:473–77. - PMC - PubMed

Publication types

MeSH terms